Brief: Granules - Granules Life Sciences Receives U.S. FDA Approval For Hyderabad Facility
11/11/2025 06:14
Nov 11 (Reuters) - Granules India Ltd GRAN.NS: GRANULES LIFE SCIENCES RECEIVES U.S. FDA APPROVAL FOR HYDERABAD FACILITY Source text: ID:nBSE6Xh4Cm Further company coverage: GRAN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake